GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3826 - 3850 of 4050 in total
Antibody Patient Onset (days) Symptom ▼ GlyTouCan ID Arbitrary Fluorescence Units (AFU)
IgG Patient 4 12 mild
G26295XE
115
IgG Patient 4 12 mild
G27689OB
52
IgG Patient 4 12 mild
G28868ZC
98
IgG Patient 4 12 mild
G29011JC
75
IgG Patient 4 12 mild
G29857RC
80
IgG Patient 4 12 mild
G30839DN
552
IgG Patient 4 12 mild
G31265MS
54
IgG Patient 4 12 mild
G32473MI
94
IgG Patient 4 12 mild
G32611KT
75
IgG Patient 4 12 mild
G32699RJ
99
IgG Patient 4 12 mild
G35446HX
259
IgG Patient 4 12 mild
G36191CD
173
IgG Patient 4 12 mild
G36374CE
381
IgG Patient 4 12 mild
G36544AC
95
IgG Patient 4 12 mild
G37036SF
166
IgG Patient 4 12 mild
G37383BH
75
IgG Patient 4 12 mild
G38488WF
67
IgG Patient 4 12 mild
G39023AU
122
IgG Patient 4 12 mild
G39213VZ
57
IgG Patient 4 12 mild
G40696TO
92
IgG Patient 4 12 mild
G41200QS
77
IgG Patient 4 12 mild
G42346AP
196
IgG Patient 4 12 mild
G42666HT
207
IgG Patient 4 12 mild
G43534QA
237
IgG Patient 4 12 mild
G43648DB
214

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024